Tempest Therapeutics Stock (NASDAQ: TPST) stock price, news, charts, stock research, profile.
You can purchase shares of Tempest Therapeutics (NASDAQ:TPST) through any online brokerage.
Other companies in Tempest Therapeutics’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Acurx Pharmaceuticals (NASDAQ:ACXP), Curis (NASDAQ:CRIS), Bolt Biotherapeutics (NASDAQ:BOLT) and Geovax Labs (NASDAQ:GOVX).
Tempest Therapeutics has a consensus price target of $18.80.
The stock price for Tempest Therapeutics (NASDAQ: TPST) is $0.9 last updated November 15, 2024 at 7:59 PM EST.
There are no upcoming dividends for Tempest Therapeutics.
Tempest Therapeutics’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for Tempest Therapeutics.
Tempest Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.